Researcher.Life Logo

Journal of bone oncology : Impact Factor & More

pISSN: 2212-1366

Key Metrics

CiteScore
3.09
H-Index
15
SNIP
1.16
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of bone oncology

Planning to publish in Journal of bone oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of bone oncology

Primary osseous malignancies of the foot: a comprehensive literature review and insights from a single-centre experience.
  • 1 Jun 2026
  • Journal of bone oncology
Health-related quality of life and physical activity in children with Multiple Osteochondromas.
  • 1 Jun 2026
  • Journal of bone oncology
Is strict use of denosumab or zoledronate Beneficial to patients with bone metastatic Disease?
  • 1 Jun 2026
  • Journal of bone oncology
Nationwide epidemiologic study of osteochondroma in Japan: Analysis of 4843 cases from the bone and soft tissue tumor registry.
  • 1 Jun 2026
  • Journal of bone oncology
Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival - a Swedish Nationwide cohort study.
  • 1 Apr 2026
  • Journal of bone oncology
Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype.
  • 1 Apr 2026
  • Journal of bone oncology
Primary osseous malignancies of the foot: a comprehensive literature review and insights from a single-centre experience.
  • 1 Jun 2026
  • Journal of bone oncology
Health-related quality of life and physical activity in children with Multiple Osteochondromas.
  • 1 Jun 2026
  • Journal of bone oncology
Is strict use of denosumab or zoledronate Beneficial to patients with bone metastatic Disease?
  • 1 Jun 2026
  • Journal of bone oncology
Nationwide epidemiologic study of osteochondroma in Japan: Analysis of 4843 cases from the bone and soft tissue tumor registry.
  • 1 Jun 2026
  • Journal of bone oncology
Metastatic renal cell carcinoma: risk of rapid progression to pathological fractures and factors influencing post-treatment survival - a Swedish Nationwide cohort study.
  • 1 Apr 2026
  • Journal of bone oncology
Doxorubicin enhances adipogenesis in an FGF2-dependent manner and induces a tumour-promoting secretory phenotype.
  • 1 Apr 2026
  • Journal of bone oncology

FAQs on Journal of bone oncology